Marilyn R. Carlson serves as Executive at Evoke Pharma Inc, where they oversee executive responsibilities. Since joining the company, Marilyn R. Carlson has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 16, 2025 involved transacting 360 shares valued at $0.
Marilyn R. Carlson currently holds 51,876 shares of Evoke Pharma Inc (EVOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Marilyn R. Carlson has been a net neutral trader of EVOK stock. They have purchased $0 and sold $0 worth of shares.
Marilyn R. Carlson's most recent insider trade was on Dec 16, 2025, when they sold 360 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.05 |
| Discretionary |
| Aug 31, 2018 | EVOK | $5.1K | Other | 3,101 | $1.63 | Discretionary |
| Aug 31, 2017 | EVOK | $8.6K | Other | 4,023 | $2.15 | Discretionary |
| Feb 28, 2017 | EVOK | $12.6K | Other | 7,875 | $1.60 | Discretionary |
| Mar 1, 2016 | EVOK | $21.3K | Other | 7,331 | $2.90 | Discretionary |
| Aug 31, 2015 | EVOK | $6.6K | Other | 1,994 | $3.31 | Discretionary |
| Feb 27, 2015 | EVOK | $28.8K | Other | 6,058 | $4.75 | Discretionary |
| Aug 29, 2014 | EVOK | $7.1K | Other | 1,256 | $5.67 | Discretionary |